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Pulmonary vein isolation (PVI) with radiofrequency ablation (RFA) is the cornerstone of
atrial fibrillation (AF) therapy, but few strategies exist for when it fails. To guide RFA, phase
singularity (PS) mapping locates reentrant electrical waves (rotors) that perpetuate AF.
The goal of this study was to test existing and develop new RFA strategies for terminating
rotors identified with PS mapping. It is unsafe to test experimental RFA strategies in
patients, so they were evaluated in silico using a bilayer computer model of the human
atria with persistent AF (pAF) electrical (ionic) and structural (fibrosis) remodeling. pAF
was initiated by rapidly pacing the right (RSPV) and left (LSPV) superior pulmonary veins
during sinus rhythm, and rotor dynamics quantified by PS analysis. Three RFA strategies
were studied: (i) PVI, roof, and mitral lines; (ii) circles, perforated circles, lines, and crosses
0.5–1.5 cm in diameter/length administered near rotor locations/pathways identified by
PS mapping; and (iii) 4–8 lines streamlining the sequence of electrical activation during
sinus rhythm. As in pAF patients, 2 ± 1 rotors with cycle length 185 ± 4 ms and short
PS duration 452 ± 401 ms perpetuated simulated pAF. Spatially, PS density had weak
to moderate positive correlations with fibrosis density (RSPV: r = 0.38, p = 0.35, LSPV:
r = 0.77, p = 0.02). RFA PVI, mitral, and roof lines failed to terminate pAF, but RFA
perforated circles and lines 1.5 cm in diameter/length terminated meandering rotors
from RSPV pacing when placed at locations with high PS density. Similarly, RFA circles,
perforated circles, and crosses 1.5 cm in diameter/length terminated stationary rotors
from LSPV pacing. The most effective strategy for terminating pAF was to streamline the
sequence of activation during sinus rhythmwith>4 RFA lines. These results demonstrate
that co-localizing 1.5 cm RFA lesions with locations of high PS density is a promising
strategy for terminating pAF rotors. For patients immune to PVI, roof, mitral, and PS
guided RFA strategies, streamlining patient-specific activation sequences during sinus
rhythm is a robust but challenging alternative.
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1. INTRODUCTION
Atrial fibrillation (AF) is a worldwide epidemic that
decreases the quality of life and increases mortality in its
victims (Go et al., 2001). From theoretical AF studies (Lewis,
1924; Allessie et al., 1977), to animal AF models (Davidenko
et al., 1990; Gray et al., 1998), to AF patients (Narayan et al.,
2012; Haïssaguerre et al., 2014), AF is driven by high-frequency
electrical activity that prevents the synchronized muscular
contractions of the left (LA) and right (RA) atrium. The
mechanism for this fibrillatory behavior can be explained by
either focal impulse generation leading to the collision of
multiple wavelets (Moe and Abildskov, 1959), or via spiraling
reentrant waves with peripheral wave breakup (Davidenko et al.,
1990). This present study focuses on the latter, where the sources
of AF are termed rotors.
To extinguish AF rotors in patients, radiofrequency ablation
(RFA) is used to create lesions that electrically isolate or destroy
AF triggers and proarrhythmic substrates. Since its identification
in the late 1990’s (Haïssaguerre et al., 1998), the cornerstone of
modern day AF treatment with RFA is pulmonary vein (PV)
isolation (PVI) (Calkins et al., 2012), which is achieved with
circular RFA lesions around the base of the right and left PVs.
When AF persists post PVI, additional lesions are delivered to
areas of complex fractionated atrial electrograms, or across the
LA roof and/or between the left PVI and mitral value opening.
PVI has an 80% success rate in patients with paroxysmal AF
(Wilber et al., 2010; Morillo et al., 2014), but has little efficacy
in patients with persistent AF (pAF) (Calkins et al., 2012). One
explanation for the latter may be that multiple rotors can exist far
from the PVs of pAF patients (Narayan et al., 2012; Haïssaguerre
et al., 2014), likely being the result of extensive electrical (Nattel
et al., 2008) and structural (Cochet et al., 2015) remodeling
throughout the LA. Therefore, without spatial knowledge on
the electrical behavior of pAF rotors in patients prior to RFA
procedures, terminating pAF can be extremely challenging with
long procedure times and excessive tissue damage from the
many unguided RFA lesions administered to extinguish all rotors
(O’Neill et al., 2009).
To improve RFA efficacy in pAF patients, the mapping of
rotor phase singularities (PS) with basket catheters (Narayan
et al., 2012) or non-invasive electrocardiographic imaging (ECGi)
systems (Haïssaguerre et al., 2014) have been developed to
help identify RFA targets that perpetuate pAF. PS mapping
has revealed that either stationary rotors (Narayan et al., 2012)
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or multiple short-lived and/or meandering rotors (Haïssaguerre
et al., 2014) underlie pAF. However, few RFA strategies have been
proven to safely and effectively terminate these targets once they
are identified. Thus, for this study it was hypothesized that safe
and effective termination of pAF rotors can be achieved with
small PS guided RFA lesions placed at locations of the LA with
high PS density. When PVI, mitral, roof, and PS guided RFA
lesions fail, it was also hypothesized that pAF can be terminated
with evenly spaced RFA lines that streamline patient-specific
LA activation sequences during sinus rhythm, which essentially
forces electrical waves to propagate unidirectionally in the LA
from early to late activation times.
Since it is unsafe to test these two hypotheses in pAF patients
(Bohnen et al., 2011), a novel computationally efficient bilayer
model of the human atria (Labarthe et al., 2014) was utilized to
test the effects of PVI, roof, mitral, PS guided, and streamlined
activation sequence RFA on pAF rotors in the LA. This model
contains both electrical and structural pAF remodeling to
simulate clinically relevant pAF and to corroborate previous AF
and RFA computational modeling studies (Rotter et al., 2007;
Reumann et al., 2008; Krueger et al., 2014; McDowell et al.,
2015). The results from this study are intended to complement
current modeling efforts toward more effective patient-specific
AF therapies in the cardiac electrophysiology clinic (McDowell
et al., 2012; Krueger et al., 2013).
2. MATERIALS AND METHODS
2.1. Atrial Bilayer Model
Several authors of this study recently contributed to the
development of a novel bilayer model of the human atria
to perform studies in silico (Labarthe et al., 2014). This
model is computationally inexpensive (see Section 2.6) without
compromising anatomical detail and electrical behavior, and was
modified to accurately simulate the atrial electrophysiology of
pAF patients (compare Tables 1, 2 with Lemery et al., 2007;
Narayan et al., 2008; Krummen et al., 2012), whichmake it ideally
suited to test the hypotheses for this study. The components of
the modified pAF bilayer model are described below.
2.1.1. Anatomy
As done in previous studies (Labarthe et al., 2012, 2014),
the anatomy of the pAF bilayer model was constructed from
segmented computed tomography (CT) scans of an adult human
heart prone to pAF (Labarthe et al., 2014). The image-based atrial
anatomy was then meshed with finite triangular elements, where
fiber orientation was incorporated into each triangular element
using a semi-automatic rule-based method that replicates the
gross atrial fiber architecture of the human atria (Labarthe et al.,
2012). The pAF bilayer model anatomy contains endocardial
and epicardial layers connected by linear elements, along with
fast conducting pathways (Bachmann’s bundle, crista terminalis,
pectinate muscles) and three distinct interatrial connections in
order to recreate known conduction pathways in human atria.
The computational mesh consists of 363,561 nodes, 718,915
triangular elements with an average edge length of 333 µm, and
143,611 linear elements with an average length of 93 µm.
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TABLE 1 | Activation times (ACT) in the pAF bilayer model during sinus
rhythm.
Region Avg. ACT ± SD (ms) Earliest ACT (ms) Latest ACT (ms)
RA 57±22 9 105
RAA 58±15 23 90
SAN 9±5 1 19
CS 94±6 82 106
SVC 39±10 18 62
IVC NA NA NA
CTS 31±10 16 54
PM 42±12 16 77
BB 59±9 41 80
LA 88±20 47 135
LAA 110±12 81 142
RSPV 71±7 56 85
RIPV 89±5 77 102
LSPV 103±6 88 117
LIPV 125±7 110 140
2.1.2. Electrophysiology
Electrophysiology parameters were finely-tuned to match
monophasic action potential duration (APD) of pAF patients
(Narayan et al., 2008; Krummen et al., 2012). In the cell model
used to simulate human atrial myocyte membrane kinetics
throughout the pAF bilayer model (Courtemanche et al., 1998),
gNa was doubled to produce realistic action potential upstroke
velocities (Labarthe et al., 2014), IK1 conductance was decreased
by 20% in order to provide a better match with clinically
measured rate adaptation data (Krummen et al., 2012), and
electrical remodeling during pAF was represented by reducing
the ionic conductances of Ito, IKur , and ICaL according to
Courtemanche et al. (1999). Second, regional repolarization
heterogeneity was incorporated following Aslanidi et al. (2011)
and Seemann et al. (2006). Third, the electrophysiology of the
pAF bilayer model was updated to include the PV and appendage
ionic model parameters of Dorn et al. (2012). In the PV, gto ×
0.75, gCaL × 0.75, gKr × 2.4, gKs × 1.87, gK1 × 0.67, and for the
appendages, IKr was 1.6 fold greater in the LA vs. RA appendage.
Lastly, the electrophysiology of the pAF bilayer model was
modified to simulate realistic sinoatrial node (SAN) activation of
the RA according to Fedorov et al. (2010) by isolating the SAN
and connecting it to four different locations on the RA body.
The conductivity values for each SAN connection were chosen
by adjusting them until conduction propagated from the SAN to
the RA, and then doubling them to ensure conduction between
the SAN and RA under all pacing conditions.
All electrophysiological parameters of the pAF bilayer model
used for this study are listed in Supplementary Tables S1–S3 of
the online supplement, and baseline activation times (according
to Section 2.4.3) and APD (at 90% repolarization) during sinus
rhythm in the pAF bilayer model are listed in Tables 1, 2. Please
note, activation times and APD in the inferior vena cava (IVC) of
the model are not available since it is not activated during sinus
rhythm. Only in rare cases is electrically active muscular tissue
TABLE 2 | Action potential duration (APD) in the pAF bilayer model during
sinus rhythm.
Region Avg. APD ± SD (ms) Shortest APD (ms) Longest APD (ms)
RA 236± 8 208 282
RAA 233± 5 212 253
SAN 300± 10 267 319
CS 227± 8 195 240
SVC 239± 7 216 273
IVC NA NA NA
CTS 246± 5 228 259
PM 237± 6 215 257
BB 237± 10 192 259
LA 205± 11 161 237
LAA 197± 5 179 217
RSPV 159± 10 140 195
RIPV 156± 8 136 183
LSPV 155± 9 139 185
LIPV 155± 7 137 181
found within the IVCs of patients (Scave et al., 2003). In elements
assigned to be non-conductive, conductivity values were set to
0.001 to prevent numerical issues from a division by zero in
the conductivity tensor of the equations governing the spread of
electrical activity in the pAF bilayer model.
2.1.3. Fibrosis
Image-based fibrosis from patients was incorporated into the
pAF bilayer model to simulate pAF consistent with other
computational studies (Krueger et al., 2014; McDowell et al.,
2015). Fibrotic distributions were assigned identically to the
epicardial and endocardial layers, and were incorporated as
microstructural discontinuities, for which mesh element edges
were stochastically selected as fibrotic. This selection depended
on statistical distributions of late-gadolinium enhancement,
averaged across a population of pAF patients (Cochet et al., 2015),
and also on the direction of a given mesh element edge compared
to the longitudinal fiber direction, i.e., the direction along fibers
(Labarthe et al., 2012). In order to model interstitial fibrosis,
mesh element edges paralleling the longitudinal fiber direction
were four times more likely to be selected than edges transversing
this direction. This was implemented by using the scaling factor
α(4cos2(θ) + sin2(θ)), where θ is the acute angle between a
mesh element edge and the longitudinal fiber direction within the
element. The constant weighting factor, α, was chosen such that
the median length of connected fibrotic mesh element edges was
670 µm, which is within the range of values reported by Spach
et al. (2007) for the length of interstitial fibrosis in aging fiber
bundles. To determine whether to select a mesh element edge as
fibrotic, each edge was assigned a uniformly distributed random
number in the interval (0, 1), and then compared to the product
of the scaling factor above with the late-gadolinium likelihood.
Mesh element edges for which this product was greater than
the random number were selected as fibrotic. In the instance
that all edges for a mesh element were selected, the element was
removed from the mesh. To impose no flux boundary conditions
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at selected edges, mesh elements edges were arranged and nodes
added following the method of Costa et al. (2014).
2.2. pAF Initiation Protocol
To simulate spontaneous initiation of pAF by ectopic beats
originating in the PVs (Haïssaguerre et al., 1998), pAF was
initiated by rapidly pacing the right superior (RSPV) and left
superior (LSPV) PVs. During sinus rhythm, which was ongoing
at 86 beats per min for all simulations, each PV was paced
individually for five beats with a cycle length (CL) of 160 ms
and coupling interval (CI) of 240 ms at the RSPV and 400 ms
at the LSPV. These values for CL and CI were taken from the
clinical study by Haïssaguerre et al. (1998). pAF was considered
self-sustained if it remained present for more than 10 s post
initiation.
2.3. pAF PS Analysis
An automated algorithm was used to determine the spatial
distribution and duration of PSs from rotors and wavebreak. The
phase of transmembrane voltage (Vm) at each computational
node was calculated using the Hilbert transform of the signal,
after subtraction of the mean (Umapathy et al., 2010). PSs were
identified by calculating the topological charge of each element in
the mesh (Rogers, 2004). PSs were tracked over time based on a
distance movement threshold (Roney et al., 2015) following the
network approach of Rogers (2004), with the modification that
PSs rather than wavefronts were tracked over time.
PS durations were then calculated based on the birth and
death of the PS, where those lasting greater than 120 ms were
defined as rotors (based on the minimum pAF CL). PS and rotor
density were calculated by counting the number of occurrences
of a PS or rotor at each mesh element over the duration of the
simulation. This score was smoothed using an inverse distance
squared weighting to give an average density measure across
the mesh, which was then normalized (Tzortzis et al., 2015).
Metrics were also considered on a regional basis by dividing the
LA into eight subdivisions, as done similarly in non-invasive PS
mapping studies (Haïssaguerre et al., 2014). The subdivided LA
location numbers 1–4 in Figures 3C, 6 correspond to posterior
LA subdivisions, and numbers 5–8 correspond to anterior LA
subdivisions. For regional analyses, the number of PSs and rotors
in each of the eight subdivisions were calculated for every time
point in the simulation (each ms), and then averaged over time
in order to calculate the mean and standard deviation of PSs and
rotors in each subdivision for any instance in time during the
simulation.
2.4. Arrhythmia Ablation Strategies
RFA was simulated in the pAF bilayer model by setting the
conductivities (longitudinal and transverse) to 0.001 S/m (non-
conducting and non-zero for numerical purposes) for mesh
elements pertaining to RFA lesions. Three RFA strategies were
applied to the LA of the pAF bilayer model, where each is
described below. Unless otherwise specified, RFA was applied 5
s post pAF initiation and analyzed over 8 s post RFA. An RFA
strategy was considered to terminate pAF if it either converted
pAF to atrial tachycardia (AT), i.e., a single rotor which can be
terminated with specific ablation at its core (Rappel et al., 2015),
or if it converted pAF back to sinus rhythm.
2.4.1. RFA with PVI, Roof, and Mitral Lines
At 5 s post pAF initiation, the right and left PVs were electrically
isolated from the LA body by a continuous RFA line around each.
If pAF persisted 5 s post PVI, a RFA roof line was administered
between the right and left PVI lines. If pAF persisted 5 s post the
RFA roof line, a RFA mitral line was administered between the
left PV RFA and the mitral valve opening.
2.4.2. PS Guided RFA with Small Lesions
For each of the eight LA subdivisions used to analyze pAF rotor
dynamics (Figures 3C, 4C), RFA lesions were administered to
each subdivision in the shape of a circle, a perforated circle to
allow wavefront penetration to prevent it from becoming an
anatomical obstacle, a line, or a cross. Each RFA lesion shape was
tested at the following dimensions: circles from 0.5 to 1.5 cm in
diameter; lines from 0.5 to 1.5 cm in length; and crosses from 0.5
to 1.5 cm in cross-sectional length. Please see the leftmost column
of Figure 6 for examples of each shape.
2.4.3. Streamlining Activation Sequences during
Sinus Rhythm with RFA Lines
During sinus rhythm, local activation times were computed
for each pAF bilayer mesh node at the instant when Vm
exceeded a threshold of –40 mV. RFA lines (sets of 4–8) were
then administered to the LA following the streamlines of the
activation sequence. These continuous RFA lines originated at
an initial point along the isochrone line 10 ms after the earliest
activation time in the LA, and ended at points around the
mitral value opening. The pathway of RFA lines between these
points followed the gradient of the local activation time sequence,
thus streamlining the activation sequence. Hence, this approach
does not target individual AF targets or substrates, but aims
to terminate all pAF rotors at once by limiting propagating
electrical activity in the LA to follow normal activation sequences
during sinus rhythm. Note, RA activation sequences were not
streamlined for this study.
2.5. Statistical Analysis
The relationships between PS density, fibrosis density, and PS
guided lesion shapes and sizes in the subdivided LA were
addressed by computing and analyzing Pearson product-moment
correlation coefficients for every combination. Values for PS
density and fibrosis density were normalized from 0 to 1 in each
LA subdivision of Figures 3C, 4C with respect to the maximum
for all subdivisions. Values for each PS guided RFA lesion shape
and size in each LA subdivision were set to 1 if it terminated
pAF, and 0 otherwise. Correlation r-values were considered
statistically significant for p ≤ 0.05.
2.6. Simulation Platform
Monodomain simulations were performed using the Cardiac
Arrhythmia Research Package CARP (Vigmond et al., 2008),
running in parallel on two high performance dual Hexa-Core
Intel Xeon X5676 nodes @ 3.06 GHz with 48 GB of memory. A
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time step of 20µs was used for all simulations, which required 83
min of computation time to solve for 1 s of simulation time.
3. RESULTS
3.1. pAF Initiation and PS Analysis
Figure 1 demonstrates the results of applying the patient derived
fibrosis to the LA of the pAF bilayer model. Self-sustained pAF
was initiated in this model via the pAF initiation protocol applied
to the RSPV and LSPV. pAF occurred via conduction block when
the paced beats from the PVs encountered an abrupt change in
fiber direction (nearly 90◦) at the base of the PVs (Figure 1B) and
longer APD in the LA body (160 vs. 220 ms). pAF was initiated in
the samemanner with fibrosis removed from thismodel (data not
shown). Figure 2 shows examples of rotors in the fibrotic LA for
both RSPV and LSPV pAF. Please see the links to Supplementary
Movies 1, 2 in section 2 of the online supplement for animations
of each pAF case. To summarize, multiple meandering rotors
were observed on the anterior and posterior surfaces of the LA
during RSPV pAF, and a figure-of-eight reentry was observed
near the left inferior PV (LIPV) during LSPV pAF.
PS analysis of pAF dynamics over the entire LAwas performed
for the pAF in Figure 2, where the results of the analysis are
provided in Figures 3A,B, 4A,B, and Table 3. For both cases of
pAF, there were on average 2.0 ± 0.6 rotors with CLs of 185 ± 4
ms and PS lifespans of 452 ± 401 ms. For the LA subdivisions
in Figure 3C, pAF phase analysis in Figure 3D revealed that
PSs occurred in subdivisions 2, 3, 5, 6, and 7, with the highest
densities in subdivisions 3, 5, and 7 corresponding to mean PSs
FIGURE 1 | Structural remodeling was incorporated probabilistically
based on late-gadolinium enhancement data. (A) Late-gadolinium
enhancement likelihood data averaged across 26 patients with pAF from
Cochet et al. (2015). (B) Longitudinal fiber directions in the pAF bilayer model.
(C) Mesh element edges selected with probability weighted by the
enhancement likelihood (A) and edge direction compared to the longitudinal
fiber direction (B). (D) Inset of the mesh showing element edges with no flux
boundary conditions imposed to create structural discontinuities. Split mesh
element edges and removed elements in (C) and (B) are marked in black.
of 1.16, 0.48, and 0.76, respectively. However, the PS density in
the subdivided LA only had a weak positive correlation with
fibrosis density (r = 0.38, p = 0.35). For the LA subdivisions in
Figures 3C, 4C, pAF phase analysis in Figure 4D revealed that
PSs occurred in subdivisions 1, 3, 4, 5, and 7, with the highest
density in subdivision 3 corresponding to a mean PS of 1.7.
Unlike with RSPV pAF, PS density in the subdivided LA had a
much stronger positive correlation with fibrosis density (r= 0.77,
p = 0.02). For reference, normalized fibrosis densities for the LA
subdivisions in Figures 3C, 4C are as follows: 1= 0.84; 2= 0.28;
3= 1.0; 4= 0.57; 5= 0.42; 6= 0.35; 7= 0.25; 8= 0.20.
For both RSPV and LSPV pAF, the highest PS densities
occurred in the posterior subdivision 3 around the LIPV
(Figures 3B, 4B). PS rotor trajectories on the LA surface during
LSPV pAF were localized namely to LA subdivision 3, but not
during RSPV pAF (compare Figures 3A, 4Awith Supplementary
FIGURE 2 | pAF initiation via PV pacing. (A) Transmembrane voltage (Vm)
map post pAF initiation via RSPV pacing. (B) Vm plot from a point in the RSPV
showing the transition of sinus rhythm to pAF via RSPV pacing. (C) Vm map
post pAF initiation via LSPV pacing. (D) Vm plot from a point in the LSPV
showing the transition of sinus rhythm to pAF via LSPV pacing. The * symbols
in (A,C) indicate the pacing sites and Vm plot locations, and the arrows
indicate the direction of rotor rotations.
Frontiers in Physiology | www.frontiersin.org 5 April 2016 | Volume 7 | Article 108
Bayer et al. Novel Atrial Fibrillation Ablation Strategies
FIGURE 3 | PS locations during pAF from RSPV pacing. (A) PS
trajectories on the posterior (shown on the left) and anterior (shown on the
right) walls, colored by time (ms) during the simulation post RSPV pacing. (B)
Spatially smoothed PS density map, indicating that one rotor is found on the
posterior wall in an area of high fibrosis density, and another moves across the
anterior wall. (C) Eight LA subdivisions were used for analysis and correspond
to the LA location numbers in Figure 6. (D) Regional assessment of the mean
and standard deviation of PSs and the mean number of rotors (shown in a
darker shade) over the duration of the simulation show that subdivisions 3, 5,
and 7 have the highest PS density. (E) Regional assessment of average CL for
each vertex in the pAF bilayer model indicates that mean average CL is
constant across subdivisions, while the minimum average CL varies (shown in
a darker shade).
Movies 1, 2). Furthermore, in LA subdivision 3 the LSPV pAF
rotors rotated counterclockwise, while RSPV pAF rotors rotated
clockwise. Therefore, spatial RSPV and LSPV pAF dynamics
differed since rotors and the wavefronts radiating from them
encountered electrical and structural heterogeneity in the LA
differently.
3.2. RFA with PVI, Roof, and Mitral Lines
Failed to Terminate pAF
RFA with PVI, roof, and mitral lines failed to terminate both
pAFs in Figure 2. As demonstrated in Figure 5B for RSPV
pAF, PVI failed to terminate the anterior pAF rotor, which
persisted even after delivering the subsequent RFA roof line.
FIGURE 4 | PS locations during pAF from LSPV pacing. (A) PS
trajectories on the posterior (shown on the left) and anterior (shown on the
right) walls, colored by time (ms) during the simulation post LSPV pacing.
(B) Spatially smoothed PS density map, indicating rotors localized only in
the area of high fibrosis density on the posterior wall. (C) Eight LA
subdivisions were used for analysis and correspond to the LA location
numbers in Figure 6. (D) Regional assessment of the mean and standard
deviation of PSs and the mean number of rotors (shown in a darker
shade) over the duration of the simulation show that subdivision 3 has the
highest PS density. (E) Regional assessment of average CL for each
vertex in the pAF bilayer model indicates that mean average CL is
constant across subdivisions, while the minimum average CL varies
(shown in a darker shade).
After delivering the final RFA mitral line, pAF persisted with a
meandering rotor on the posterior LA body next to the LIPV.
This same sequence of RFAs in Figure 5A failed to terminate
LSPV pAF, and had little effect on the figure-of-eight reentry near
the LIPV.
3.3. PS Guided RFA with Small Lesions
Terminated pAF
Small RFA lesions delivered to locations of the LA with high PS
density terminated pAF. The LA rotors either anchored to the
PS guided RFA lesion to become the dominant rotor to convert
pAF to AT, or it terminated the pAF completely and allowed sinus
rhythm to resume. Figures 6B,C reveals that RFAwith perforated
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TABLE 3 | pAF properties in the LA.
Property RSPV pacing LSPV pacing Patients References
Mean CL (ms) 182 ± 4 187 ± 4 179 ± 36 Haïssaguerre
et al., 2014
Mean number
of PS
2.7 ± 1.4 2.4 ± 1.0 NA
Mean number
of rotors
2.1 ± 0.9 1.9 ± 0.3 2.1 ± 1.0 Narayan
et al., 2012
Mean rotor
duration (ms)
419 ± 447 485 ± 355 449 ± 89 Haïssaguerre
et al., 2014
circles and lines 0.5–1.5 cm in diameter/length terminated pAF
when placed at LA locations with moderate to high PS density
(subdivision= normalized PS density from Figure 3: 3= 1.0; 6=
0.14; 7 = 0.65). Figures 6A,D reveals different outcomes when
placing solid circles or crosses 0.5–1.5 cm in diameter/length at
LA locations with low to moderate PS density (subdivision =
normalized PS density from Figure 3: 2 = 0.08; 5 = 0.42; 6 =
0.14). Figure 7 shows an example of these differences when
applying each RFA lesion shape 1.5 cm in diameter/length to
LA subdivision 3, where only the perforated circle and line
terminated pAF, while the solid circle and cross did not. For
the more stationary figure-of-eight reentry during LSPV pAF,
Figures 6A,B,D reveals that RFA with circle, perforated circle,
and cross lesions 1.5 cm in diameter/length terminated pAFwhen
placed in LA subdivision 3, which had the highest density of
rotors, PSs, and fibrosis. Please see the links for Supplementary
Movies 3–17 in section 2 of the online supplement for animations
of each successful termination of pAF from RSPV pacing, and
the links for Supplementary Movies 18–20 for a few examples of
failed attempts.
To quantify the results in Figures 6A–D, every combination of
RFA lesion shape and size with PS and fibrosis density were tested
for positive correlation. The results in Table 4 reveal PS guided
with RFA perforated circles and lines had the strongest positive
correlation with PS density (r = 0.78, p = 0.02) during RSPV
pAF. Specifically, perforated circles 1.5 cm in diameter and lines
1.5 cm in length terminated pAF at LA locations with the highest
PS density, but failed at locations of low PS density. Similar results
were found for LSPV pAF, where a solid circle, perforated circle,
and cross RFA lesion 1.5 cm in diameter/length had the strongest
correlation with PS density (r = 0.97, p= 0.00).
3.4. Streamlining Activation Sequences
during Sinus Rhythm Most Effectively
Terminated pAF
Activation times computed during sinus rhythm in the LA
(Figure 8A) reveal the earliest LA activation time to occur on the
anterior LA body just below the RSPV. By administering evenly
spaced continuous RFA lines that streamlined the activation time
sequence in Figure 8B, RSPV pAF was immediately terminated
with 5–8 RFA lines, but not with four (Figures 8C,D). Please see
SupplementaryMovie 21 to better visualize the rapid termination
of RSPV pAF when streamlining with five RFA lines. Identical
results were obtained for LSPV pAF.
FIGURE 5 | RFA with PVI, mitral, and roof lines failed to terminate AF
from RSPV pacing. (A) RFA starting with PVI, followed by a roof line, and
then a mitral line. (B) Transmembrane voltage (Vm) maps showing pAF rotor
behavior after the respective RFA in (A). The arrows indicate the direction of
rotor rotations.
4. DISCUSSION
A computer model of pAF in the human LA was used to study
both existing and novel RFA strategies for terminating AF. With
this approach, it was determined that RFA with PVI, roof, and
mitral lines failed to terminate pAF rotors far from the PVs,
and likewise for small RFA lesions placed at LA locations not
intersecting pAF rotor pathways. In contrast, PS guided RFA
lesions 1.5 cm in diameter or length more effectively terminated
pAF when placed at LA locations of high PS density. In the case
that pAF rotors cannot be terminated with a combination of PVI,
roof, mitral, and small PS guided RFA lesions, streamlining the
sequence of electrical activation in the LA with > 4 continuous
RFA lines immediately terminated pAF. The results from this
study support the hypotheses that small RFA lesions guided by
PSmaps is a safe and effective pAF therapy, and that streamlining
activation sequences during sinus rhythm with continuous RFA
lines is an alternative pAF termination approach when all else
fails. The clinical relevance, impact, and translation of this study’s
results are discussed below.
4.1. Corroboration of Simulated and
Patient pAF
There is much debate as to whether pAF rotors identified
with PS mapping using basket catheters have stationary rotor
PSs (Narayan et al., 2012), or meandering/short-lived rotor
PSs as detected non-invasively with ECGi PS mapping systems
(Haïssaguerre et al., 2014). The results from this study show
that both cases are feasible under different circumstances. When
initiating pAF from rapidly pacing the RSPV, multiple rotors
existed and meandered, rather than staying at locations of the
LA with the highest fibrosis density. In contrast, when initiating
pAF from rapidly pacing the LSPV, rotors lingered at the location
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FIGURE 6 | PS guided RFA terminates pAF from RSPV and LSPV pacing. The effects of PS guided RFA administered to the eight LA subdivision locations in
Figures 3C, 4C with circles (A), perforated circles (B), lines (C), or crosses (D) 1.5 cm in diameter/length on pAF initiated via RSPV or LSPV pacing: being either by
terminating pAF back to sinus rhythm (green +); converting pAF to AT (yellow +); or no change with pAF persisting (red X).
FIGURE 7 | Outcomes for PS guided RFA for pAF from RSPV pacing.
(A) RFA lesion shapes used for PS guided RFA with a diameter or length of 1.5
cm. (B) Transmembrane Voltage (Vm) maps 5 s post RFA in (A) showing pAF
to either persist, terminate into sinus rhythm, or convert to AT. The arrows
indicate the direction of rotor rotations.
of the pAF bilayer model with the highest fibrosis density, thus
appearing stationary. In either case, pAF rotor PS statistics in
the pAF bilayer model (Table 3) mirrored those obtained from
clinical PS maps (Narayan et al., 2012; Haïssaguerre et al., 2014),
which is compelling evidence that the pAF bilayer model was able
to simulate clinically relevant pAF in order to properly test this
study’s hypotheses.
Secondly, terminating pAF rotors with RFA in the pAF
bilayer model was difficult without a robust strategy devised a
priori. This is consistent with the normal everyday challenges
cardiac electrophysiologists encounter with RFA procedures.
Particularly, the RFA with PVI, roof, and mitral lines failed
to terminate pAF when pAF rotors existed far from the PVs
(Figure 5), as well as failure with small RFA lesions placed at LA
locations with low PS density (compare LA subdivisions 1, 4, and
8 in Figures 3C,D with Figure 6 and Table 4). Based on these
results, the difficulty of PVI, roof, mitral, and small unguided
RFA lesions to consistently terminate pAF rotors in all patients is
unsurprising. Therefore, the novel RFA strategies developed from
this study, both the small RFA lesions guided by PS mapping and
the RFA lines that streamline activation sequences during sinus
rhythm, are intended to provide clinicians with more strategic
tools to effectively extinguish rotors that perpetuate pAF.
4.2. The Role of Fibrosis in the Termination
of pAF Rotors
In a recent study by Chrispin et al. (2015), they found a lack of
regional association between late gadolinium enhancement and
pAF rotors in the LA of pAF patients. Based on these results,
they concluded that fibrosis density is not guaranteed to correlate
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TABLE 4 | Correlations of PS guided RFA lesions, fibrosis density, and PS
density.
Fibrosis density PS density
R-value P-value R-value P-Value
RSPV pacing
PS density 0.38 0.35 – –
RFA lesion shape and size
Circle 0.5 cm −0.19 0.65 −0.16 0.70
Circle 1.0 cm −0.29 0.48 −0.06 0.88
Circle 1.5 cm – – – –
Perforated Circle 0.5 cm −0.19 0.65 −0.16 0.70
Perforated Circle 1.0 cm −0.40 0.33 0.18 0.67
Perforated Circle 1.5 cm 0.71 0.05 0.78 0.02
Line 0.5 cm 0.13 0.77 0.69 0.06
Line 1.0 cm −0.19 0.65 −0.16 0.70
Line 1.5 cm 0.71 0.05 0.78 0.02
Cross 0.5cm −0.10 0.82 0.14 0.73
Cross 1.0cm −0.29 0.48 −0.06 0.88
Cross 1.5 cm – – – –
LSPV pacing
PS density 0.77 0.02 – –
RFA lesion shape and size
Circle 0.5 cm – – – –
Circle 1.0 cm – – – –
Circle 1.5 cm 0.71 0.05 0.97 0.00
Perforated Circle 0.5 cm – – – –
Perforated Circle 1.0 cm – – – –
Perforated Circle 1.5 cm 0.71 0.05 0.97 0.00
Line 0.5 cm – – – –
Line 1.0 cm – – – –
Line 1.5 cm – – – –
Cross 0.5cm – – – –
Cross 1.0cm – – – –
Cross 1.5 cm 0.71 0.05 0.97 0.00
Bold values represent the maximal positive correlation between PS guided RFA results
and either fibrosis or PS density.
with the location of pAF rotors. In this study, a definitive positive
correlation between PS and fibrosis density was not observed
(see Table 4). Therefore, rather than targeting fibrosis density for
RFA, it was more advantageous to target locations in the LA with
the highest PS density over time, which did not always coincide
with LA locations with the highest fibrosis density (compare
Figure 1 and Figure 3).
A possible explanation for the inconclusive cause and effect
relationship between fibrosis and PS density may be that specific
fibrotic architectures are needed to generate or anchor pAF
rotors. Therefore, when fibrosis density is high, the existence
of unique fibrotic patterns that generate or anchor pAF may
increase, but is not necessarily guaranteed. This line of thought
supports the notion that patient-specific modeling of fibrosis
is a critical tool to help guide AF therapies in the cardiac
electrophysiology clinic (McDowell et al., 2013).
FIGURE 8 | Streamlining the sequence of LA activation during sinus
rhythm with >4 lines effectively terminates pAF from RSPV pacing. (A)
LA activation times during sinus rhythm at 86 beats per min. (B) four or five
RFA lines that streamline the activation time sequence in (A). (C)
Transmembrane voltage (Vm) maps 5 s post streamlining showing
unsuccessful pAF termination with four RFA lines, but successful pAF
termination with five RFA lines. (D) Vm plotted at the point indicated by the * in
(A) before and after streamlining with four and five RFA lines.
Nevertheless, one thing that is certain from these studies
is that the distribution of fibrosis alters pAF rotor dynamics.
When repeating the pAF initiation protocol in the pAF bilayer
model with a more sparse and less dense distribution of fibrosis
from a single patient in Cochet et al. (2015), PS analysis
revealed significantly different pAF rotor dynamics (compare
Figures 1C,D, 3, 4 with the Supplementary Figures 1, 2). These
results are consistent with other computational modeling studies
of AF and fibrosis (Krueger et al., 2014; McDowell et al., 2015).
Though in contrast to the study by McDowell et al. (2015),
PSs in this study were not always anchored and stationary.
Therefore, placing RFA lesions directly over PSs did not always
terminate pAF (compare Figure 3 and Figure 6), which is
common behavior for RFA lesions applied to unanchored rotor
PSs (Rappel et al., 2015).
4.3. Clinical Impact and Translation of the
Novel RFA Strategies
In the clinical setting, RFA is typically performed first
to terminate all rotors maintaining pAF, followed by pAF
inducibility tests to identify pAF triggers for further RFA. Thus,
RFA strategies for the former should be timely, effective, and
minimally destructive. To help clinicians achieve these goals, two
novel RFA strategies were developed in silico for extinguishing
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pAF rotors identified with clinical PS mapping systems. The
clinical impact and translation of each to the bedside are
discussed below.
4.3.1. Small RFA Lesions Guided by PS Mapping
This study demonstrates that terminating pAF is feasible with
single RFA lesions administered to atrial locations with high PS
density. Therefore, by investigating pAF rotor dynamics in PS
maps from patients prior to an RFA procedure, this study predicts
that targeting atrial locations with the highest PS density with
small RFA lesions 1.5 cm in diameter/length will more effectively
terminate rotors driving pAF in patients. In comparison to RFA
strategies utilizing traditional low-resolution contact mapping
(O’Neill et al., 2009), guided strategies with high-resolution
PS mapping formulated before the RFA procedure could help
cardiac electrophysiologists minimize RFA tissue damage and
procedure times to preserve atrial function.
The technology needed to translate this PS guided RFA
approach to the bedside is already in place. PS mapping
systems compatible with atria imaged with CT and
magnetic resonance imaging (MRI) have been cleared for
clinical use and are available on the commercial market
(www.cardioinsight.com). Likewise, conventional RFA catheters
to deliver simple lines made of contiguous spot lesions, as
well as perforated or contiguous circular lesions, are also
commercially available (BW, nMARQ). Therefore, it is feasible
that clinical trials could be conducted in the near future to
validate the PS guided RFA results obtained from this in silico
study.
Another technical issue that needs to be addressed is the
combination of PS guided RFA lesions with PVI to isolate pAF
triggers. In particular, does the order of the RFA alter pAF rotor
dynamics? It is feasible that PS density distributions in the LA
change significantly after each RFA administered to the patient.
Therefore, real-time PS mapping may need to accompany PS
guided RFA strategies in the clinic in order to obtain real-
time PS maps that continually update the clinician with RFA
targets.
The last technical issue to discuss is in regard to the level
of precision needed for a clinician to target specific PS in the
complex LA geometry. In the case that RFA locations in this study
are difficult for clinicians to achieve with traditional X-ray setups,
millimeter spatial precision could be achieved with interventional
MRI systems for cardiac electrophysiology (Bhagirath et al.,
2015). There is a growing market for MRI compatible
catheters, defibrillators, etc. to make this possible in the
near future.
4.3.2. RFA Lines Streamlining the Sequence of
Activation during Sinus Rhythm
This one-size-fits-all strategy developed for terminating pAF
rotors with RFA lines that streamline the sequence of activation
during sinus rhythm was inspired by the Cox-Maze procedure
(CMP) (Cox et al., 1991). The first CMP was performed in
1987 using a cut-and-sew technique to generate a maze with
lanes smaller than the critical mass for stable rotors (Garrey,
1914), thereby terminating and preventing macroreentrant pAF
circuits. Similar to the CMP, this novel strategy for streamlining
atrial activation sequences during sinus rhythm with RFA lines
subdivides the atria into sections too small to harbor pAF rotors,
which eliminates the need to target individual pAF locations and
substrates.
Today, many variations of the CMP exist, which are less
invasive by substituting incisions with RFA or cryoenergy lesions
when possible, and are incredibly effective at terminating pAF
rotors (85% pAF free at 10 year followup) (Weimar et al., 2012).
However, CMPs remain prone to surgical complications due
to their complexity and invasiveness when compared to RFA
only procedures. CMPs also carry the risk of excessive scarring
and tissue destruction, which can disrupt the normal electro-
mechanical function of the atria. To minimize the dangers
associated with CMPs, the RFA streamlining approach does not
require destructive incisions, and requires only five RFA lines
in the LA to prevent the formation and maintenance of pAF
rotors. In other words, the RFA streamlining approach preserves
normal electrical propagation in the LA during sinus rhythm
by subdividing the LA into lanes too small to harbor pAF, but
not small enough to cause macroreentry from unidirectional
conduction block within a lane.
Translating the RFA streamlining approach to the bedside is
much more technically challenging than PS guided RFA with
smaller lesions. This is due to the fact that it is technically
difficult for a clinician to quickly burn long continuous lesions
over wide-areas. With technological advancements in RFA
catheter designs, catheter steering systems, and MRI assisted
RFA, though, this challenging but robust RFA strategy could
first be validated in large animal studies, and then eventually
in patients. Furthermore, it will be necessary to determine the
best possible approach for obtaining patient-specific electrical
activation sequences during sinus rhythm, either by trusted
invasive methods (PentaRay NAV catheters) or by experimental
methods tracking electrical activity on the atrial surfaces with
ECGi (Ghanem et al., 2005).
4.4. Limitations
The first limitation of this study is that RFA lesions are delivered
instantaneously, not sequentially as done in the clinic. Thus,
it is feasible that RFAs administered slowly over time would
alter pAF dynamics and potentially the outcome of the RFA
strategies. However, this is unlikely the case for the PS guided
RFA strategy since the shape dimensions used were ≤1.5 cm in
diameter/length, so the time required for clinicians to generate
these lesions should be minimal. Secondly, fibrosis is modeled
as an average density across an entire patient population. Thus,
patient-specific distributions of fibrosis that are significantly
different than the cohort average may produce different pAF
initiation and termination outcomes. Subsequent studies should
identify how patient-specific differences in fibrosis density and
spatial heterogeneity influence the outcome of the RFA strategies.
Third, fibrosis is modeled via mesh element edge splitting rather
than changes in cellular ionic properties (McDowell et al., 2015)
or low conductivity (Krueger et al., 2014), which could alter
pAF rotor dynamics. However, it us unknown how each of the
three methods, or the combination of, most accurately models
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fibrosis, which warrants a future comparison study. Fourth,
the way the LA was subdivided may bias the pAF and PS
guided RFA analyses. For example, if a high PS density is
detected in the LA appendage, RFA lesions applied to the body
and not the appendage within LA subdivision 7 may have a
lower chance of terminating pAF, thus weakening the positive
correlation of pAF termination with PS guided RFA lesions and
PS density. Future work will explore if finer subdivisions of the
LA are needed. Fifth, variations in atrial wall tissue thickness
(Ho et al., 1999) may affect pAF rotor dynamics (Yamazaki
et al., 2012). In the current study, all layers in the pAF bilayer
model have uniform thickness. If the need for specific and/or
varied layer thickness arises in prospective studies, it can be
easily added on an element by element basis in the pAF bilayer
modeling methodology (Labarthe et al., 2014). Sixth, the atrial
cell model used for this study (Courtemanche et al., 1998) is
extremely sensitive to changes in the maximal conductance of
IK1. To avoid unrealistic shortening of APD in the pAF bilayer
model, which would alter pAF rotor dynamics, large increases
in IK1 from pAF as modeled by other groups (Colman et al.,
2013) were omitted from this study. Lastly, the pAF bilayer
model does not include mechanical contraction which may alter
pAF rotor dynamics, but the effects of mechanical contraction
(quiver during pAF) on pAF rotor dynamics remains largely
unknown.
5. CONCLUSION
RFA strategies for terminating pAF rotors have vastly different
outcomes in silico. This study demonstrates that RFA with PVI,
roof, and mitral lines fail to terminate pAF when rotors are
far from the PVs, and likewise for small RFA lesions placed
at LA locations with low PS density. In contrast, circle, line,
and cross RFA lesions 1.5 cm in diameter/length terminate pAF
when guided to locations of the LA with high PS density. In
the case that PVI, roof, mitral, and PS guided RFA lesions
fail to extinguish rotors perpetuating pAF, streamlining the
sequence of LA activation during sinus rhythm with > 4 RFA
lines is a robust alternative strategy to immediately terminate
pAF. Further study is needed to verify the clinical relevance of
these promising novel RFA strategies before translating them to
the bedside.
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